Semaglutide 10mg Semaglutide is a GLP-1 receptor agonist research compound studied in laboratory and pre-clinical models involving incretin signaling, glucose-response pathways, and metabolic regulation.

Researchers investigate Semaglutide for its relevance in GLP-1 receptor activity studies, metabolic signaling research, and energy-balance models.

SLU-PP-332 5mg SLU-PP-332 is a synthetic research compound studied in laboratory settings for its potential interaction with estrogen-related receptor signaling pathways and metabolic activity models.

Researchers investigate SLU-PP-332 in pre-clinical studies involving mitochondrial function, energy expenditure pathways, exercise-mimetic signaling, and metabolic adaptation research.